Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • efoss
    Member
    • Jul 2011
    • 98

    GATK RealignerTargetCreator -B and -D options

    The GATK RealignerTargetCreator has two options for inputting data about known SNPs:



    java -Xmx1g -jar /path/to/GenomeAnalysisTK.jar \
    -T RealignerTargetCreator \
    -R /path/to/reference.fasta \
    -o /path/to/output.intervals \
    [-I /path/to/input.bam] \
    [-L intervals] \
    [-B:snps,VCF /path/to/SNP_calls.vcf] \
    [-B:indels,VCF /path/to/indel_calls.vcf] \
    [-D /path/to/dbsnp.rod]
    Explanation of Arguments
    The -L option is used to restrict the search to a specific region or set of regions instead of the whole genome.
    The -o argument is used to specify the list of intervals being output and that should in turn be passed to the realigner in the next step.
    The -B snps binding would be used to pass in SNP calls so that the target creator can find clustered SNPs.
    The -B indels and dbsnp bindings would be used to pass in known indel sites for the realigner to target.

    I don't understand the difference between the -B and the -D options. I have used the -B option often with this file (from the GATK resource bundle):

    00-All.vcf

    I saw that the resource bundle also has a file called "dbsnp_132.b37.vcf", and I'm tempted to use that with the -D option, but I really don't know what I'm doing with that. Does anyone understand the difference between these options?

    Thank you.

    Eric
  • yasashiku
    Member
    • Jul 2011
    • 12

    #2
    I think
    Code:
    -D <file name>
    was the old way of doing
    Code:
    -B:dbsnp,VCF <file name>
    But now (with the latest version of GATK), it looks like the -B option is deprecated? Now I think you want to use:
    Code:
    -known:dbsnp,VCF <file name>
    I could be wrong, especially about the recent changes. If I am, someone please correct me

    Given that they're the same option, I doubt giving it two different files is a good idea (I bet it will crash if you try).
    Last edited by yasashiku; 10-03-2011, 09:21 AM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    212 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...